ProShare Advisors’s Amneal Pharmaceuticals AMRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$469K Sell
37,696
-3,685
-9% -$49.5K ﹤0.01% 1102
2025
Q4
$521K Buy
41,381
+4,461
+12% +$51K ﹤0.01% 1114
2025
Q3
$370K Sell
36,920
-5,641
-13% -$50.6K ﹤0.01% 1287
2025
Q2
$344K Sell
42,561
-5,869
-12% -$44.2K ﹤0.01% 1350
2025
Q1
$406K Sell
48,430
-11,063
-19% -$92.3K ﹤0.01% 1211
2024
Q4
$471K Buy
59,493
+29,424
+98% +$247K ﹤0.01% 1307
2024
Q3
$250K Buy
30,069
+13,742
+84% +$107K ﹤0.01% 1585
2024
Q2
$104K Sell
16,327
-5,575
-25% -$35.4K ﹤0.01% 1659
2024
Q1
$133K Buy
21,902
+1,726
+9% +$9.73K ﹤0.01% 1769
2023
Q4
$122K Buy
20,176
+4,341
+27% +$19.3K ﹤0.01% 1751
2023
Q3
$66.8K Sell
15,835
-19
-0.1% -$71 ﹤0.01% 1688
2023
Q2
$49.1K Buy
15,854
+3,733
+31% +$7.95K ﹤0.01% 1773
2023
Q1
$16.8K Sell
12,121
-1,132
-9% -$2.25K ﹤0.01% 1744
2022
Q4
$26.4K Buy
13,253
+1,900
+17% +$4.26K ﹤0.01% 1793
2022
Q3
$23K Sell
11,353
-216
-2% -$605 ﹤0.01% 1711
2022
Q2
$37K Sell
11,569
-7,137
-38% -$25.9K ﹤0.01% 1734
2022
Q1
$78K Sell
18,706
-3,076
-14% -$13.6K ﹤0.01% 2071
2021
Q4
$105K Buy
21,782
+9,006
+70% +$44.9K ﹤0.01% 2194
2021
Q3
$68K Sell
12,776
-13,094
-51% -$65.9K ﹤0.01% 1949
2021
Q2
$132K Sell
25,870
-654
-2% -$3.72K ﹤0.01% 2242
2021
Q1
$179K Buy
26,524
+4,552
+21% +$25.2K ﹤0.01% 2068
2020
Q4
$100K Buy
21,972
+9,816
+81% +$43.5K ﹤0.01% 1988
2020
Q3
$47K Sell
12,156
-1,324
-10% -$5.66K ﹤0.01% 1598
2020
Q2
$64K Buy
+13,480
New +$55.5K ﹤0.01% 1617
2020
Q1
Sell
-16,027
Closed -$77K 1183
2019
Q4
$77K Buy
16,027
+5,353
+50% +$18.6K ﹤0.01% 1717
2019
Q3
$31K Sell
10,674
-480
-4% -$1.68K ﹤0.01% 1629
2019
Q2
$80K Sell
11,154
-1,484
-12% -$15.2K ﹤0.01% 1552
2019
Q1
$179K Buy
12,638
+1,161
+10% +$15.3K ﹤0.01% 1499
2018
Q4
$155K Sell
11,477
-1,790
-13% -$32.3K ﹤0.01% 1420
2018
Q3
$294K Buy
13,267
+39
+0.3% +$821 ﹤0.01% 1369
2018
Q2
$217K Buy
+13,228
New +$232K ﹤0.01% 1569

Other funds holding AMRX